Gene · 3799
Papers2,390
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,390
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A TRAK2-KIF5B complex mediates microtubule-based LDL vesicle transport during endothelial transcytosis. | J Lipid Res | 2026 | 42767506 | PubTator, text mining | PubMed |
| Psilocybin prevents chemotherapy-induced peripheral neuropathy through mitochondrial trafficking preservation. | Science | 2026 | 42691184 | PubTator, text mining | PubMed |
| De Novo Actionable Genomic Alterations in High-Grade Pulmonary Neuroendocrine Carcinomas: Therapeutic Implications of Targeted Treatment. | Med Sci (Basel) | 2026 | 42646625 | PubTator, text mining | PubMed |
| Bile extracellular vesicles for early cholangiocarcinoma detection in primary sclerosing cholangitis. | JHEP Rep | 2026 | 42628796 | PubTator, text mining | PubMed |
| Development and Characterization of a Patient-Derived KIF5B-RET Fusion Lung Adenocarcinoma Cell Line for Subcutaneous and Central Nervous System Tumor Models in Immunodeficient Mice. | JTO Clin Res Rep | 2026 | 42568736 | PubTator, text mining | PubMed |
| Insights into how JIP3 and JIP4 adaptor proteins relieve the auto-inhibited form of the kinesin-1 motor. | J Biol Chem | 2026 | 42486258 | PubTator, text mining | PubMed |
| TWEAK/FN14 inhibition synergizes with oncogene-directed tyrosine kinase inhibitors to overcome resistance across multiple driver contexts. | Sci Rep | 2026 | 42399307 | PubTator, text mining | PubMed |
| Case Report: KIF5B-ALK-rearranged renal cell carcinoma. | Front Oncol | 2026 | 42376664 | PubTator, text mining | PubMed |
Metformin Activates AMP-Activated Protein Kinase-Transcription Factor EB Signaling to Restore Lysosomal and Mitochondrial Homeostasis and Suppress Epithelial-to-Mesenchymal Transition in Oxidative Stress-Injured Retinal Pigment Epithelium. | Am J Pathol | 2026 | 42276413 | PubTator, text mining | PubMed |
| An engineered streptavidin condensate platform for chemically inducible control of endogenous proteins in mammalian cells. | bioRxiv | 2026 | 42244538 | PubTator, text mining | PubMed |
| Clonal relationship in a rare pulmonary mixed tumor: shared ALK fusion in atypical carcinoid and adenocarcinoma-a case report. | Transl Lung Cancer Res | 2026 | 42170278 | PubTator, text mining | PubMed |
| Brigatinib in ALK-fused, Low-grade Pediatric Angiocentric Glioma with Multiple Extracranial Metastases: A Case Report. | CNS Neurol Disord Drug Targets | 2026 | 42136297 | PubTator, text mining | PubMed |
| FDA-approved RET protein-tyrosine kinase inhibitors in the management of RET-driven thyroid and lung cancer. | Pharmacol Res | 2026 | 42107510 | PubTator, text mining | PubMed |
| Molecular Characterisations and the Association with Clinical Factors in RET Fusion-Positive NSCLC: A Retrospective Study of the Single Center Cohort. | Cancer Manag Res | 2026 | 42088459 | PubTator, text mining | PubMed |
| A Retrospective, Multicenter Analysis Within the National Network Genomic Medicine Lung Cancer in Germany to Detect RET Fusions as a Possible Mechanism of Resistance in Patients With EGFR Mutations. | Clin Lung Cancer | 2026 | 42055889 | PubTator, text mining | PubMed |
| Reversal of Paraneoplastic Non-Bacterial Thrombotic Endocarditis with Heparin and Targeted Cancer Therapy: A Case Report. | Reports (MDPI) | 2026 | 41893435 | PubTator, text mining | PubMed |
| Snapshot on Cell-to-Cell Communication Nanotubes: From Bacteria to Humans. | Biology (Basel) | 2026 | 41892274 | PubTator, text mining | PubMed |
| PACS1 syndrome mutation disrupts dynein-mediated cargo transport via HDAC6 and BICD2. | Commun Biol | 2026 | 41888583 | PubTator, text mining | PubMed |
| Stall force measurement of the kinesin-3 motor KIF1A using a programmable DNA origami nanospring. | Elife | 2026 | 41879504 | PubTator, text mining | PubMed |
| KIF5B and Dynein-Dependent Golgi Organization: Role in Adhesion-Dependent Microtubule Acetylation. | Traffic | 2026 | 41866246 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3799/papers